Evidence map›Paper›PMID 36154838›Full record

ReviewEuropean journal of medical research2022

Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.

Hayder M Al-Kuraishy, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, Ali I Al-Gareeb, Mohammed Alorabi, Michel De Waard, Sarah M Albogami, Gaber El-Saber Batiha

Open access · goldAbstract readReview
In one paragraph

Review in European journal of medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
25.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Exploring the clinical effects ofFrontiers in pharmacology · 2025
    Pooled it
  2. Pooled it
  3. Experimental evaluation ofExperimental and therapeutic medicine · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. The Binding of Brazilin fromInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Irisin/PGC-1α/FNDC5 pathway in Parkinson's disease: truth under the throes.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  19. Review
  20. Role of fenofibrate in multiple sclerosis.European journal of medical research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Hayder M Al-KuraishyDepartment of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Baghdad, Iraq.
Omnia Momtaz Al-FakhranyPharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Engy ElekhnawyPharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt. Engy.ali@pharm.tanta.edu.eg.
Ali I Al-GareebDepartment of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Baghdad, Iraq.
Mohammed AlorabiDepartment of Biotechnology, College of Sciences, Taif University, P.O.Box 11099, Taif, 21944, Saudi Arabia.
Michel De WaardSmartox Biotechnology, 6 rue des Platanes, 38120, Saint-Egrève, France.
Sarah M AlbogamiDepartment of Biotechnology, College of Science, Taif University, P.O.Box 11099, Taif, 21944, Saudi Arabia.
Gaber El-Saber BatihaDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt. gaberbatiha@gmail.com.
Alsalam University College · IQTaif University · SATanta University · EGDamanhour University · EGLaboratoire d'Excellence Canaux Ioniques d'Intérêt Thérapeutique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, the coronavirus (COVID-19) pandemic is a chief public health disaster caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are no established effective preventive or therapeutic anti-COVID-19 drugs available except for some recently approved vaccines. Still, countless recent studies recommend various alternative and complementary approaches against COVID-19, which are medicinal herbs employed as traditional remedies to enhance immunity to struggle with viral infections. In addition, physicians worldwide are highly interested in vitamin and mineral supplements to help them combat COVID-19 either through protection or treatment. Dietary supplements specifically vitamin D, vitamin C, and zinc provide good prophylactic and therapeutic support to the presently available treatment regimens. In the present work, we have focused on plant-based remedies with promising anti-COVID-19 activities.

aimTo enable investigators and researchers to identify potential herbal compounds with anti-COVID activity to be used as promising therapies to combat this pandemic. MAIN BODY: This review highlights the recently published studies concerning natural traditional herbs, herbal bioactive metabolites, dietary supplements, and functional foods that could help prevent and/or treat COVID-19. Herein, we explored medicinal herbs as potential inhibitors of SARS-CoV-2 and discussed how these studies help form larger discussions of diet and disease. Moreover, by investigating the herbal bioactive components, we have outlined several medicinal herbs that can fight against COVID-19 by hindering SARS-CoV-2 replication and entry to its host cells, deterring the cytokine storm, and several other means. Finally, we have summarized various herbal products, functional foods, and dietary supplements with potent bioactive compounds which can inhibit and/or prevent COVID-19 disease progression.

conclusionsBased on the studies reviewed in this work, it was concluded with no doubt that phytochemical components present in various herbs could have a starring role in the deterrence and cure of coronavirus contagion.

Indexed as

COVID-19 Drug TreatmentPlants, MedicinalAscorbic AcidHumansPandemicsPhytochemicalsSARS-CoV-2Vitamin DVitaminsZincAscorbic AcidPhytochemicalsVitamin DVitaminsZincBioactive metabolitesCOVID-19Functional foodsNutraceuticalsPhytochemicalsTraditional Chinese medicine

Identifiers

PMID36154838
PMCPMC9510171
OpenAlexW4297198432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.